A Rapid Screening Test on Dried Blood for the Neonatal Diagnosis of Tyrosinemia Type I|
Bodaghkhan, Farahnaz; Geramizadeh, Bita; Rajeh, Abbas Abdollah; Haghighat, Mahmoud; Dehghani, Mohsen; Honar, Naser; Zahmatkeshan, Mojgan & Imanieh, Mohammad-Hadi
Background: Tyrosinemia is an inherited metabolic disorder characterized by elevated levels of tyrosine and its metabolites in
plasma. Without treatment, the disease will progress to hepatic and renal failure, so that without liver transplantation will cause
death in less than 10 years of age. So, early diagnosis and treatment can be life saving and crucial. It means that with early treatment
starting in the neonatal period, the patient can have normal life with very few restrictions in diets containing tyrosine and
Objectives: In this study we wanted to evaluate an easy to perform, rapid and sensitive qualitative test with low cost, as a part of
neonatal screening tests to help early diagnosis and treatment of hereditary tyrosinemia.
Patients and Methods: In this cross sectional study, during the study period (2013 - 2014), 100 patients were selected. Fifty three (53)
of these patients had proven tyrosinemia and the other 47 cases biliary atresia, paucity of intrahepatic bile ducts, cytomegalovirus
(CMV) hepatitis, galactosemia and storage diseases.
Results: There were 2 false negative and 14 false positive cases of hereditary tyrosinemia (HT-1) in the test. Six cases of biliary atresia,
7 cases of paucity of intrahepatic bile ducts and one patient with cytomegalovirus (CMV) hepatitis were falsely positive with the test.
Sensitivity of the test was 96.23%, specificity 71.43%, positive predictive value (PPV) 78.46%, and negative predictive value (NPV) 94.59%.
Conclusions: This rapid qualitative test on dried blood sample is an easy, cheap, and feasible method for the screening of hereditary
tyrosinemia in neonatal period.
Hereditary Tyrosinemia Type I; Succinylacetone; Screening Test; Newborn